Close

Analyst Ratings for Taysha Gene Therapies (TSHA)

TSHA Rating Summary

TSHA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TSHA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $27.40 (+1319.7%) * Over Last 12-Mos
Rating Score: 9.3 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/9/2022 Baird Jack Allen New Coverage Outperform
(N/A)
26.00
(N/A)
5.74
(1.93)
-66.38% Details
3/1/2022 Wells Fargo
» Updated 8/12/2022
N/A New Coverage Overweight
(N/A)
20.00
(25.00)
6.37
(1.93)
-69.7% Details
Like TSHA Ratings? Also take a look at OMER, OPK

TSHA Ratings News